Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice

Journal of Clinical Psychiatry

Volumn 75, Issue 1, 2014, Pages 8-14

  Papakostas, George I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CATECHOLAMINE DERIVATIVE; DULOXETINE; ESCITALOPRAM; MODAFINIL; PLACEBO; PSYCHOSTIMULANT AGENT; S ADENOSYLMETHIONINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VORTIOXETINE;

ADD ON THERAPY; ADJUVANT THERAPY; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; COGNITION; COGNITIVE DEFECT; DEPRESSION; DISEASE DURATION; EXECUTIVE FUNCTION; HUMAN; INFORMATION RETRIEVAL; MAJOR DEPRESSION; MEDLINE; MEMORY; META ANALYSIS (TOPIC); ONSET AGE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REVIEW; RISK FACTOR; SAMPLE SIZE; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT RESISTANT DEPRESSION;

COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; HUMANS;

EID: 84893129070     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13r08710     Document Type: Review

References (39)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association; 2013.
2. Pandina GJ, Revicki DA, Kleinman L, et al. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician-and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial. J Affect Disord. 2009;118(1-3): 139-146. doi:10.1016/j.jad.209.02.019 PubMed
3. Jaeger J, Berns S, Uzelac S, et al. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145(1):39-48. doi:10.1016/j.psychres.205.1.01 PubMed
4. McCall WV, Dunn AG. Cognitive deficits are associated with functional impairment in severely depressed patients. Psychiatry Res. 2003;121(2): 179-184. doi:10.1016/j.psychres.203.09.03 PubMed
5. Morimoto SS, Gunning FM, Murphy CF, et al. Executive function and shortterm remission of geriatric depression: the role of semantic strategy. Am J Geriatr Psychiatry. 2011;19(2):115-122. doi:10.1097/JGP.0b013e3181e751c4 PubMed
6. Alexopoulos GS, Meyers BS, Young RC, et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry. 2000; 57(3):285-290. doi:10.101/archpsyc.57.3.285 PubMed
7. Davidson RJ, Pizzagalli D, Nitschke JB, et al. Depression: perspectives from affective neuroscience. Annu Rev Psychol. 2002;53(1):545-574. doi:10.146/anurev.psych.53.10901.135148 PubMed
8. Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol. 2001;11(2):240-249. doi:10.1016/S0959-438(0)0203-8 PubMed
9. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci. 1997;9(3):471-481. PubMed
10. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull. 2003;65(1):193-207. doi:10.1093/bmb/65.1.193 PubMed
11. Phillips ML, Drevets WC, Rauch SL, et al. Neurobiology of emotion perception, 2: implications for major psychiatric disorders. Biol Psychiatry. 2003;54(5):515-528. doi:10.1016/S06-323(03)0171-9 PubMed
12. Diener C, Kuehner C, Brusniak W, et al. A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. Neuroimage. 2012;61(3):677-685. doi:10.1016/j.neuroimage.2012.04.05 PubMed
13. Hasselbalch BJ, Knorr U, Kessing LV. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord. 2011;134(1-3):20-31. doi:10.1016/j.jad.2010.1.01 PubMed
14. McClintock SM, Husain MM, Greer TL, et al. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology. 2010;24(1):9-34. doi:10.1037/a01736 PubMed
15. Mendelsohn D, Riedel WJ, Sambeth A. Effects of acute tryptophan depletion on memory, attention and executive functions: a systematic review. Neurosci Biobehav Rev. 2009;33(6):926-952. doi:10.1016/j.neubiorev.209.03.06 PubMed
16. Hollon SD, Shelton RC, Wisniewski S, et al. Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. J Psychiatr Res. 2006;40(1):59-69. doi:10.1016/j.jpsychires.205.07.08 PubMed
17. Wagner S, Doering B, Helmreich I, et al. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment. Acta Psychiatr Scand. 2012;125(4):281-292. doi:10.1/j.160-047.201.01762.x PubMed
18. Lee RS, Hermens DF, Porter MA, et al. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord. 2012;140(2):113-124. doi:10.1016/j.jad.201.10.023 PubMed
19. Castaneda AE, Suvisaari J, Marttunen M, et al. Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity. J Affect Disord. 2008;110(1-2):36-45. doi:10.1016/j.jad.207.12.239 PubMed
20. Castaneda AE, Marttunen M, Suvisaari J, et al. The effect of psychiatric co-morbidity on cognitive functioning in a population-based sample of depressed young adults. Psychol Med. 2010;40(1):29-39. doi:10.1017/S0329170905959 PubMed
21. McDermott LM, Ebmeier KP. A meta-analysis of depression severity and cognitive function. J Affect Disord. 2009;119(1-3):1-8. doi:10.1016/j.jad.209. 04.02 PubMed
22. McLennan SN, Mathias JL. The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review. Int J Geriatr Psychiatry. 2010;25(10):933-944. doi:10.102/gps.2431 PubMed
23. Sheline YI, Pieper CF, Barch DM, et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry. 2010;67(3):277-285. doi:10.101/archgenpsychiatry.209.204 PubMed
24. Fava M, Graves LM, Benazzi F, et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry. 2006;67(11):1754-1759. doi:10.408/JCP.v67n13 PubMed
25. Hasselbalch BJ, Knorr U, Hasselbalch SG, et al. Cognitive deficits in the remitted state of unipolar depressive disorder. Neuropsychology. 2012;26(5): 642-651. doi:10.1037/a029301 PubMed
26. Hasselbalch BJ, Knorr U, Hasselbalch SG, et al. The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder. Eur Psychiatry. 2013;28(6):349-355. doi:10.1016/j.eurpsy.2012.03.04 PubMed
27. Bora E, Harrison BJ, Yucel M, et al. Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med. 2013;43(10):2017-2720. PubMed
28. Douglas KM, Porter RJ. Longitudinal assessment of neuropsychological function in major depression. Aust N Z J Psychiatry. 2009;43(12):1105-1117. doi:10.3109/04867090327987 PubMed
29. Maalouf FT, Brent D, Clark L, et al. Neurocognitive impairment in adolescent major depressive disorder: state vs trait illness markers. J Affect Disord. 2011; 133(3):625-632. doi:10.1016/j.jad.201.04.041 PubMed
30. Fava M, Iosifescu DV, Pedrelli P, et al. Reliability and validity of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire. Psychother Psychosom. 2009;78(2):91-97. doi:10.159/0201934 PubMed
31. Raskin J, Wiltse CG, Siegal A, et al. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry. 2007; 164(6):900-909. doi:10.176/api.ajp.164.6.90 PubMed
32. Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Guzmán D, et al. Effects of selective serotonin reuptake and dual serotonergic- noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. J Psychiatr Res. 2009;43(9):855-863. doi:10.1016/j.jpsychires.208.10.015 PubMed
33. Herrera-Guzmán I, Herrera-Abarca JE, Gudayol-Ferré E, et al. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatry Res. 2010;177(3):323-329. doi:10.1016/j. psychres.2010.03.06 PubMed
34. Katona C, Hansen T, Olsen CK. A randomized, double-blind, placebocontrolled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol. 2012;27(4):215-223. doi:10.1097/YIC. 0b013e3283542457 PubMed
35. Herrera-Guzmán I, Gudayol-Ferré E, Lira-Mandujano J, et al. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder. Psychiatry Res. 2008; 160(1):72-82. doi:10.1016/j.psychres.207.04.012 PubMed
36. Levkovitz Y, Alpert JE, Brintz CE, et al. Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. J Affect Disord. 2012;136(3): 1174-1178. doi:10.1016/j.jad.201.04.059 PubMed
37. Papakostas GI, Mischoulon D, Shyu I, et al. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry. 2010;167(8):942-948. doi:10.176/api.ajp.209.0908198 PubMed
38. DeBattista C, Lembke A, Solvason HB, et al. A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol. 2004;24(1):87-90. doi:10.1097/01.jcp.0104910.75206.b9 PubMed
39. Alexopoulos GS, Raue PJ, Kiosses DN, et al. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry. 2011;68(1):33-41. doi:10.101/archgenpsychiatry.2010.17 PubMed